MedTrace Logo

A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID

NCT07694232 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-07-09

No results posted yet for this study

Summary

A small-scale test of the intervention, trial design and methods to explore the cumulative effectiveness of two commonly used prescribing strategies for patients with long COVID: Treatment A - prescribing a specific homeopathic remedy for long COVID, plus or minus Treatment B - a course of individually tailored treatment by a homeopath. Both interventions compared to usual care

Conditions

Interventions

OTHER

Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID

prescription of a specific homeopathic remedy for long COVID

OTHER

a course of individually tailored treatment by a homeopath

A series of up to four consultations with a homeopath, one month apart, and at the end of each consultation the homeopath prescribes an individually tailored homeopathic remedy

Sponsors & Collaborators

  • Institute for Ethical Research Governance

    collaborator UNKNOWN

  • Homeopathy International

    collaborator UNKNOWN

  • St. Mary's University, Twickenham

    lead OTHER

Principal Investigators

  • Clare Relton, PhD · Queen Mary University of London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-15
Primary Completion
2028-07-01
Completion
2028-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07694232 on ClinicalTrials.gov